<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Kazukauskiene N</submitter><pubmed_abstract>This study aimed to examine the influence of thyroid hormone (TH) levels and genetic polymorphisms of deiodinases on long-term outcomes after acute myocardial infarction (AMI). In total, 290 patients who have experienced AMI were evaluated for demographic, clinical characteristics, risk factors, TH and NT-pro-BNP. Polymorphisms of TH related genes were included deiodinase 1 (DIO1) (rs11206244-C/T, rs12095080-A/G, rs2235544-A/C), deiodinase 2 (DIO2) (rs225015-G/A, rs225014-T/C) and deiodinase 3 (DIO3) (rs945006-T/G). Both all-cause and cardiac mortality was considered key outcomes. Cox regression model showed that NT-pro-BNP (HR = 2.11; 95% CI = 1.18- 3.78; p = 0.012), the first quartile of fT3, and DIO1 gene rs12095080 were independent predictors of cardiac-related mortality (HR = 1.74; 95% CI = 1.04-2.91; p = 0.034). The DIO1 gene rs12095080 AG genotype (OR = 3.97; 95% CI = 1.45-10.89; p = 0.005) increased the risk for cardiac mortality. Lower fT3 levels and the DIO1 gene rs12095080 are both associated with cardiac-related mortality after AMI.</pubmed_abstract><journal>Scientific reports</journal><pagination>9169</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7280282</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Importance of Thyroid Hormone level and Genetic Variations in Deiodinases for Patients after Acute Myocardial Infarction: A Longitudinal Observational Study.</pubmed_title><pmcid>PMC7280282</pmcid><pubmed_authors>Kazukauskiene N</pubmed_authors><pubmed_authors>Mickuviene N</pubmed_authors><pubmed_authors>Brozaitiene J</pubmed_authors><pubmed_authors>Zaliunaite V</pubmed_authors><pubmed_authors>Skiriute D</pubmed_authors><pubmed_authors>Gustiene O</pubmed_authors><pubmed_authors>Burkauskas J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Importance of Thyroid Hormone level and Genetic Variations in Deiodinases for Patients after Acute Myocardial Infarction: A Longitudinal Observational Study.</name><description>This study aimed to examine the influence of thyroid hormone (TH) levels and genetic polymorphisms of deiodinases on long-term outcomes after acute myocardial infarction (AMI). In total, 290 patients who have experienced AMI were evaluated for demographic, clinical characteristics, risk factors, TH and NT-pro-BNP. Polymorphisms of TH related genes were included deiodinase 1 (DIO1) (rs11206244-C/T, rs12095080-A/G, rs2235544-A/C), deiodinase 2 (DIO2) (rs225015-G/A, rs225014-T/C) and deiodinase 3 (DIO3) (rs945006-T/G). Both all-cause and cardiac mortality was considered key outcomes. Cox regression model showed that NT-pro-BNP (HR = 2.11; 95% CI = 1.18- 3.78; p = 0.012), the first quartile of fT3, and DIO1 gene rs12095080 were independent predictors of cardiac-related mortality (HR = 1.74; 95% CI = 1.04-2.91; p = 0.034). The DIO1 gene rs12095080 AG genotype (OR = 3.97; 95% CI = 1.45-10.89; p = 0.005) increased the risk for cardiac mortality. Lower fT3 levels and the DIO1 gene rs12095080 are both associated with cardiac-related mortality after AMI.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2024-02-14T23:22:21.402Z</modification><creation>2020-06-20T07:07:29Z</creation></dates><accession>S-EPMC7280282</accession><cross_references><pubmed>32514186</pubmed><doi>10.1038/s41598-020-66006-9</doi></cross_references></HashMap>